CID 137964141

2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1h-imidazole; acetic acid

Structural Information

Molecular Formula
C16H31BN2O3Si
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN(C(=N2)C)COCC[Si](C)(C)C
InChI
InChI=1S/C16H31BN2O3Si/c1-13-18-14(17-21-15(2,3)16(4,5)22-17)11-19(13)12-20-9-10-23(6,7)8/h11H,9-10,12H2,1-8H3
InChIKey
RTWDAGJFMGNDAD-UHFFFAOYSA-N
Compound name
trimethyl-[2-[[2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazol-1-yl]methoxy]ethyl]silane
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

338.2197 Da
Monoisotopic Mass

None
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 339.22698 173.4
[M+Na]+ 361.20892 181.9
[M-H]- 337.21242 179.1
[M+NH4]+ 356.25352 190.8
[M+K]+ 377.18286 182.4
[M+H-H2O]+ 321.21696 168.8
[M+HCOO]- 383.21790 189.8
[M+CH3COO]- 397.23355 210.2
[M+Na-2H]- 359.19437 175.7
[M]+ 338.21915 181.0
[M]- 338.22025 181.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.